Compositions and methods for identifying and targeting...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C436S064000

Reexamination Certificate

active

06844153

ABSTRACT:
Screening and diagnostic reagents, kits and methods for metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed. Vaccines compositions and methods of for treating and preventing metastatic colorectal cancer or primary and/or metastatic stomach or esophageal cancer are disclosed.

REFERENCES:
patent: 5601990 (1997-02-01), Waldman
patent: 5879656 (1999-03-01), Waldman
patent: 6130043 (2000-10-01), Billing-Medel et al.
patent: WO 0020640 (2000-04-01), None
Bai et al (Cancer Lett 2002 Feb. 8;176(1):47-55, abstract only).*
Mallo, et al., Int J Cancer, 1997, 74:35-44.*
Iannettoni, M.D. et al., “Detection of Barrett's aenocarcinoma of the gastric cardia with sucrase isomaltase and p53”,Ann. Thorac. Surg., 1996, 62, 1460-1466.
Mallo, G.V., et al., “Molecular cloning, sequencing and expression of the MRNA encloding human Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression during colorectal carcinogenesis,”Int. J. Cancer(Pred. Oncol), 1997, 74, 35-44.
Wu, G.D., et al., “Sucrase-isomaltase gene expression in barrett's esophagus and adenocarcinoma,”Gastroenterology, 1993, 105, 837-844.
Cagir, B., et al., “Guanylyl cyclase C messenger RNA is a biomarker for recurrent stage II colorectal cancer,”Am. Soc. Internal Med., 1999, 131(11), 805-812.
Li,Z., et al., “Peptide-regulated guanylate cyclase pathways in rat colon: in situ localization of GCA, GCC, and guanylin mRNA,”Am. Physiological Soc., 1993, G394-G402.
London, R.M., et al., “Signal transduction pathways via guanylin uroguanylin in stomach and intestine,”Am. Physiological Soc., 1997, G93-G105.
Mallo, G.V., et al., “Expression of theCdx1andCdx2homeotic genes leads to reduced malignancy in colon cancer-derived cells,”J. Biological Chem., 1998, 273(22), 14030-14036.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods for identifying and targeting... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods for identifying and targeting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for identifying and targeting... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3434043

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.